Although obesity and insulin resistance are not typical findings in HNF1A-MODY, emerging evidence suggests that environmental and metabolic modifiers, such as maternal hyperglycemia during pregnancy or underlying metabolic syndrome, may influence disease expression [51, 52]. Here, HNF1A is linked to metabolic syndrome.